<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00778804</url>
  </required_header>
  <id_info>
    <org_study_id>4159</org_study_id>
    <nct_id>NCT00778804</nct_id>
  </id_info>
  <brief_title>Preventing Heart Disease in Underserved Patients</brief_title>
  <official_title>Preventing Heart Disease in Underserved Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Temple University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Geisinger Clinic</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Insight Telehealth Systems</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
    <collaborator>
      <agency>Pennsylvania Department of Health</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Temple University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study will evaluate the impact of an internet based telemedicine system on cardiovascular&#xD;
      risk profile of underserved patient populations. It is our hypothesis that a treatment plan&#xD;
      and frequent communication via an internet based Telemedicine system will improve the&#xD;
      cardiovascular risk profile of underserved patient populations at increased risk for&#xD;
      cardiovascular disease. Our primary endpoint is a reduction over one year in the 10-year CVD&#xD;
      risk score (ATP III risk model).&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The Insight Telehealth system (ITSMyHealthfile) is a disease-managment interactive health&#xD;
      care delivery system. Patients access the system through a special Web site using a password.&#xD;
      The system prompts the patient to enter their weight, blood pressure and heart rate and there&#xD;
      is a text box available for unstructed comments.&#xD;
&#xD;
      Patients will be randomized to either the telemedicine group or usual care group (controls).&#xD;
      Individuals in the telemedicine group will be asked to transmit their health status weekly.&#xD;
      Both groups will be followed for one year with quarterly visits.&#xD;
&#xD;
      Patients of either sex, of any ethnic background or race, between 22 and 85years of age, who&#xD;
      have a 10% or greater 10-year risk of CVD based on the Framingham risk score, and risk&#xD;
      factors that if properly treated would reduced the risk by 5% or greater will be eligible for&#xD;
      the study.&#xD;
&#xD;
      Additional criteria&#xD;
&#xD;
        -  literate&#xD;
&#xD;
        -  telephone access&#xD;
&#xD;
        -  ablility to utilize the Internet and telemedicine system (after training) Primary&#xD;
           Outcome Reduction in Framingham risk index&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>July 2004</start_date>
  <completion_date type="Actual">February 2007</completion_date>
  <primary_completion_date type="Actual">February 2007</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Framingham 10-year risk index</measure>
    <time_frame>1 year</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Blood pressure, cholesterol, 6 minute walk test, glucose and A1c, CVD knowledge and risk perception</measure>
    <time_frame>1 year</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">465</enrollment>
  <condition>Hypertension</condition>
  <condition>Diabetes Mellitus</condition>
  <condition>Hyperlipidemia</condition>
  <arm_group>
    <arm_group_label>telemedicine</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Web-based monitoring in addition to usual clincial care with quarterly visits</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Ususal care with quarterly visits</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>telemedicine</intervention_name>
    <description>Weekly transmission of health status (weight, activity, BP etc.) via the Internet with feeedback and reinforcement</description>
    <arm_group_label>telemedicine</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Framingham risk score equal to or greater than 10%&#xD;
&#xD;
          -  literacy&#xD;
&#xD;
          -  22 -85 years of age&#xD;
&#xD;
          -  access to phone&#xD;
&#xD;
               -  ability to use Internet and system following training&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Class 3 and 4 heart failure&#xD;
&#xD;
          -  ESRD&#xD;
&#xD;
          -  stroke with residual disability or dementia&#xD;
&#xD;
          -  unable to read or write&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>22 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Alfred A Bove, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Temple University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Geisinger Medical Center</name>
      <address>
        <city>Danville</city>
        <state>Pennsylvania</state>
        <zip>17822</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Temple University Hospital</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19140</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Temple University Hosptial</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19140</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>October 2008</verification_date>
  <study_first_submitted>October 22, 2008</study_first_submitted>
  <study_first_submitted_qc>October 22, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 23, 2008</study_first_posted>
  <last_update_submitted>October 22, 2008</last_update_submitted>
  <last_update_submitted_qc>October 22, 2008</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 23, 2008</last_update_posted>
  <responsible_party>
    <name_title>Catherine Becker</name_title>
    <organization>Pennsylvania Department of Health</organization>
  </responsible_party>
  <keyword>CVD risk</keyword>
  <keyword>self monitoring</keyword>
  <keyword>Internet</keyword>
  <keyword>telemedicine</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Diseases</mesh_term>
    <mesh_term>Hyperlipidemias</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

